MainboardDRHP filedOffer-document study

Advanta Enterprises Limited IPO

Agriculture and agrochemicals · DRHP 19 Jan 2026

Follow this IPOband, bidding, allotment and listing, on Telegram

DRHP filed
19 Jan 2026

UPL's global seeds business, hybrid seeds sold in 74 countries, plus the Decco post-harvest treatment business, is listing through a sale of up to 36,105,578 shares by UPL and investors; the company raises nothing. Revenue was ₹5,566 crore in FY25 at an EBITDA margin of 24.73%. The company was set up in 2022, had negative net worth at March 2023 because of how the businesses were transferred in, and lists under the route for issuers that do not meet the standard tests.

Advanta Enterprises IPO: key figures

From the offer document; each figure is cited in the study below. Placings are among the 231 mainboard issues newboard has studied

Growth

Revenue CAGR FY23 to FY25
13.9%higher than 29% of studied issues
PAT CAGR FY23 to FY25
23.7%higher than 27% of studied issues
EBITDA margin FY23 → FY25
22.7% → 24.7%higher than 79% of studied issues

Issue

Fresh issue
none
Offer for sale
36,105,578 shares

Balance sheet

Net worth, September 2025
₹7,321.3 cr
Total borrowings, September 2025
₹41.1 cr

Worth reading

Free cash flow FY25
₹360.2 cr
Cases against promoters
39 criminal, 130 tax, 32 regulatory, ₹836.4 cr
Net working capital days, six months to September 2025
190higher than 88% of studied issues

Share an interesting fact, not just a link

Pick one. The post writes itself, with the page the figure is on and the picture to go with it.

Send itWhatsAppXLinkedInTelegram Card
On this page (25 sections)
  1. Key figures
  2. The study
  3. At a glance
  4. The business, in plain words
  5. Where the money comes from
  6. The growth record
  7. What the growth is made of
  8. Earnings quality
  9. The balance sheet
  10. What the money is for
  11. Who is selling
  12. Promoters
  13. Who already owns it
  14. What changed just before the IPO
  15. Capacity and expansion
  16. Market size and industry structure
  17. Competitive position
  18. Peers the company named
  19. Risks, in plain words
  20. Litigation and regulatory matters
  21. Related-party transactions
  22. What the offer document does not say
  23. Five questions for management
  24. Before the IPO
  25. Questions answered

Advanta Enterprises Limited: what the offer document says

Published 3 Oct 2026 · 2,240 words · read from the DRHP

01At a glance

What the company does: breeds, produces and markets hybrid seeds, more than 900 varieties across 21 breeding crops, and through Decco sells post-harvest treatments for fruit and vegetables (DRHP p.22).

Who pays it: farmers through distributors, dealers and retailers worldwide; the Americas were 40.30% of revenue in the six months to September 2025 and India 34.30% (DRHP p.26, DRHP p.154, our arithmetic). Field corn was 54.01% of seeds revenue in that period (DRHP p.26).

Why it is raising money: it is not. The offer is a sale of shares by UPL and the investors Melwood Holdings II and KIA EBT Scheme 2, and the company receives no proceeds (DRHP p.22, DRHP p.23).

How fast it has grown: revenue from ₹42,917 million in FY23 to ₹55,657 million in FY25, growing 16.42% and 11.39%, and ₹30,670 million in the six months to September 2025 (DRHP p.154).

The one thing to understand: a large, profitable business newly assembled for listing. The company was incorporated on 2 June 2022 and UPL transferred the seeds business to it from 1 December 2022; the accounting for that and the post-harvest acquisition left net worth at negative ₹5,428.45 million in March 2023 (DRHP p.24, DRHP p.73). Investors and UPL group entities have since acquired shares, and net worth reached ₹73,212.84 million by September 2025 (DRHP p.24, DRHP p.343).

02The business, in plain words

A seed company breeds parent lines, has contract farmers grow hybrid seed from them, cleans and packs it, often at third-party plants, and sells it before each planting season through distributors.

A maize farmer in the Americas or India plans the season's crop → the local dealer stocks Advanta hybrid corn seed → Advanta had it grown by contract growers and processed a season earlier → the farmer pays the dealer, and the dealer pays Advanta.

Contract growers produced 98.77% of seed volume in the six months, and third-party tolling plants processed 67.26% (DRHP p.26). Research and development cost 7.46% of revenue (DRHP p.154).

Earnings equation: Profit ≈ seed volume × (price − grower, processing and distribution cost) − R&D − overheads. Gross margin was 61.87% and EBITDA margin 26.49% in the six months (DRHP p.154).

03Where the money comes from

Revenue, ₹ millionFY23FY24FY25H1 FY26
Americas17,706.4120,216.7421,141.7112,360.75
India9,342.9511,140.5613,330.8910,519.89
Asia-Africa excluding India8,964.1310,747.0512,449.425,327.20
Australia and Europe6,903.897,860.658,735.382,462.18
Total42,917.3849,965.0055,657.4030,670.02

Source: DRHP p.154. The Australia and Europe row is our arithmetic. H1 FY26 is six months.

Revenue by business, ₹ millionFY23FY24FY25H1 FY26
Seeds35,584.2941,475.9046,330.7226,066.27
Post-harvest (Decco)7,333.098,489.109,326.684,603.75

Source: DRHP p.154.

04The growth record

₹ million, restated consolidatedFY23FY24FY25H1 FY26
Revenue from operations42,917.3849,965.0055,657.4030,670.02
EBITDA9,755.9311,538.7213,765.158,123.92
EBITDA margin22.73%23.09%24.73%26.49%
Profit for the period6,026.937,998.319,215.345,399.36
Free cash flow5,332.733,732.353,601.56(5,696.97)

Source: DRHP p.24, DRHP p.154. H1 FY26 is six months.

05What the growth is made of

Steady growth across regions, with margin expansion: EBITDA margin rose from 22.73% in FY23 to 24.73% in FY25 (DRHP p.154). The six months to September 2025 carried a large share of Indian sales and field corn, and free cash flow was negative ₹5,696.97 million as net working capital rose to 190 days; the document lists seasonality among its top risks (DRHP p.26, DRHP p.154).

06Earnings quality

Profits are real and cash-generative over full years, free cash flow was 54.66%, 32.35% and 26.16% of EBITDA in FY23 to FY25 to but declining as a share (DRHP p.154). Return-on-equity figures are distorted by the negative starting net worth; the document also gives adjusted return on equity of 25.04%, 16.66% and 14.38% for FY23 to FY25 (DRHP p.154). The company and some subsidiaries have made losses in the past (DRHP p.26).

There are no auditor qualifications that have not been given effect in the restated accounts (DRHP p.24). Trade receivable days were 103 in FY23, 108 in FY24, 122 in FY25 and 128 for the six months to September 2025 (DRHP p.572).

07The balance sheet

₹ millionMar 2023Mar 2024Mar 2025Sep 2025
Net worth(5,428.45)5,170.7423,189.7373,212.84
Total borrowings1,976.622,183.812,949.73411.49

Source: DRHP p.24.

The negative net worth in March 2023 arose from an amalgamation adjustment reserve on the common-control acquisition of the post-harvest and seeds businesses (DRHP p.73). In 2025 Alpha Wave Ventures II and UPL Corporation acquired shares, and Advanta's Mauritius subsidiary acquired Decco Holdings UK (DRHP p.343).

08What the money is for

Use of proceeds₹ million
Paid to the selling shareholdersnot yet stated
Received by the companynil

Source: DRHP p.22, DRHP p.23.

The offer is made under Regulation 6(2) of the SEBI rules because the company did not meet the net-tangible-asset and net-worth conditions of Regulation 6(1)(a) and 6(1)(c) in the preceding years; at least 75% of the net offer must therefore go to qualified institutional buyers (DRHP p.631).

09Who is selling

SellerHolding before the offer
UPL Limited (promoter)64.32%
Melwood Holdings II Pte. Ltd. (investor)11.07%
KIA EBT Scheme 2 (investor)negligible

Source: DRHP p.23. The cover page gives the split: UPL Limited up to 28,107,578 shares, Melwood Holdings II Pte. Ltd. up to 7,995,390 and KIA EBT Scheme 2 up to 2,610, a total of 36,105,578 (DRHP p.2).

10Promoters

The promoter is UPL Limited (DRHP p.22). Proceedings against UPL include 39 criminal, 130 tax and 32 regulatory matters involving ₹8,363.86 million (DRHP p.25).

11Who already owns it

Holder, before the offerShare
UPL Limited64.32%
UPL Corporation Limited (promoter group)13.89%
Melwood Holdings II11.07%
Alpha Wave Ventures II10.71%

Source: DRHP p.23.

12What changed just before the IPO

  • Formation: company incorporated in June 2022; seeds business transferred from UPL in December 2022 (DRHP p.73).
  • New shareholders: Alpha Wave Ventures II and UPL Corporation in 2025 (DRHP p.343).
  • Decco: acquisition of Decco Holdings UK in 2025 (DRHP p.343).
  • Debt: borrowings cut from ₹2,950 million to ₹411 million in six months (DRHP p.24).
  • Split and bonus: the face value was sub-divided from ₹10 to ₹1 in August 2024, and a bonus issue of four shares for every one held was allotted on 11 September 2024 (DRHP p.134).
  • Last allotment: 50,146,636 shares were allotted to UPL Corporation Limited at ₹855 on 25 September 2025, after 10,909,093 shares to Alpha Wave Ventures II, LP at ₹796.40 in March 2025 (DRHP p.101).
  • Public company: the company became a public limited company in October 2022 (DRHP p.2); there has been no change of statutory auditor in the three years before the filing (DRHP p.127), and no pre-IPO placement is contemplated (DRHP p.45).

13Capacity and expansion

Production relies on contract growers and processing partly on third-party plants (DRHP p.26). No expansion is funded by the offer (DRHP p.23).

14Market size and industry structure

The industry report cited in the offer document estimates the global seeds market at $51.9 billion in CY2025, forecast to reach $68.0 billion by CY2030, and the post-harvest treatment market at $2.1 billion, forecast to reach $3.0 billion (DRHP p.22). Those forecasts are the report's, and newboard has not tested them.

15Competitive position

What the document claims, and what it rests on:

  • Proprietary germplasm built over more than 50 years of R&D (DRHP p.22).
  • Global reach: seeds sold in 74 countries (DRHP p.22).

Against that: weather and crop-disease risk, dependence on field corn and the Americas, reliance on contract growers and tolling plants, and seasonality (DRHP p.25, DRHP p.26).

16Peers the company named

Company, latest yearRevenue, ₹ mnP/ERoNW
Advanta Enterprises (FY25)55,657.40-38.33%
PI Industries79,778.0030.0316.35%
Bayer CropScience54,734.0035.9019.93%
KWS SAAT155,146.9711.6213.60%
Sakata Seed52,365.6620.025.72%

Source: DRHP p.152. Peer P/E uses prices on 7 January 2026. The table also lists Corteva (DRHP p.152).

No P/E is possible for the company until a price band is set.

17Risks, in plain words

  • Weather and disease. Crop failures affect supply and demand (DRHP p.25).
  • Production costs. About 38% of revenue (DRHP p.26).
  • Contract growers. Short-term, seasonal arrangements (DRHP p.26).
  • Field corn. More than half of recent seeds revenue (DRHP p.26).
  • Americas. About 40% of revenue (DRHP p.26).
  • Seasonality. Sales and cash swing through the year (DRHP p.26).

18Litigation and regulatory matters

Proceedings outstandingCount₹ million
Against the company, criminal, regulatory, consumer15, 47, 4419.09
Against subsidiaries, tax16174.96
Against directors, tax, civil2, 1434.53
Against the promoter, criminal, tax, regulatory39, 130, 328,363.86

Source: DRHP p.25. The 15 criminal proceedings against the company arose from notices by statutory authorities (DRHP p.25). The company has filed 37 criminal proceedings (DRHP p.25).

20What the offer document does not say

In the sections read for this study, the document does not give:

  • What the statutory notices behind the 15 criminal proceedings concern, in the pages read.
  • What Alpha Wave and UPL Corporation paid for their shares in 2025, in the pages read.
  • How the offer is split among UPL, Melwood and KIA EBT.
  • Ongoing arrangements with UPL for brands, distribution or services, in the pages read.
  • The price band, lot size or issue dates, which is normal at DRHP stage.

21Five questions for management

  1. What services, brands or distribution does the company still rely on UPL for, and on what terms?
  2. What did the 2025 investors pay per share?
  3. What are the criminal proceedings against the company about?
  4. How exposed is the business to one crop, field corn, and one region, the Americas?
  5. Why did free cash flow turn negative in the six months to September 2025?

1Sources and cited facts

This study was read from 1 document the company filed. The 64 figures it cites are listed under the document each came from, with the page and the sentence as printed.

Show all 64 cited facts, with the page and the sentence as printed
Advanta Enterprises Limited DRHPdrhp · filed 2026-01-1964 facts
  1. 1
    At a glanceWhat the company does, breeds, produces and markets hybrid seeds, more than 900 varieties across 21 breeding crops, and through Decco sells post-harvest treatments for fruit and vegetables (DRHP p.22).p.22

    “What the company does, breeds, produces and markets hybrid seeds, more than 900 varieties across 21 breeding crops, and through Decco sells post-harvest treatments for fruit and vegetables (DRHP p.22).”

  2. 2
    At a glanceField corn was 54.01% of seeds revenue in that period (DRHP p.26).p.26

    “Field corn was 54.01% of seeds revenue in that period (DRHP p.26).”

  3. 3
    At a glanceHow fast it has grown, revenue from ₹42,917 million in FY23 to ₹55,657 million in FY25, growing 16.42% and 11.39%, and ₹30,670 million in the six months to September 2025 (DRHP p.154).p.154

    “How fast it has grown, revenue from ₹42,917 million in FY23 to ₹55,657 million in FY25, growing 16.42% and 11.39%, and ₹30,670 million in the six months to September 2025 (DRHP p.154).”

  4. 4
    The business, in plain wordsContract growers produced 98.77% of seed volume in the six months, and third-party tolling plants processed 67.26% (DRHP p.26).p.26

    “Contract growers produced 98.77% of seed volume in the six months, and third-party tolling plants processed 67.26% (DRHP p.26).”

  5. 5
    The business, in plain wordsResearch and development cost 7.46% of revenue (DRHP p.154).p.154

    “Research and development cost 7.46% of revenue (DRHP p.154).”

  6. 6
    The business, in plain wordsGross margin was 61.87% and EBITDA margin 26.49% in the six months (DRHP p.154).p.154

    “Gross margin was 61.87% and EBITDA margin 26.49% in the six months (DRHP p.154).”

  7. 7
    What the growth is made ofSteady growth across regions, with margin expansion: EBITDA margin rose from 22.73% in FY23 to 24.73% in FY25 (DRHP p.154).p.154

    “Steady growth across regions, with margin expansion: EBITDA margin rose from 22.73% in FY23 to 24.73% in FY25 (DRHP p.154).”

  8. 8
    Earnings qualityProfits are real and cash-generative over full years, free cash flow was 54.66%, 32.35% and 26.16% of EBITDA in FY23 to FY25 to but declining as a share (DRHP p.154).p.154

    “Profits are real and cash-generative over full years, free cash flow was 54.66%, 32.35% and 26.16% of EBITDA in FY23 to FY25 to but declining as a share (DRHP p.154).”

  9. 9
    Earnings qualityReturn-on-equity figures are distorted by the negative starting net worth; the document also gives adjusted return on equity of 25.04%, 16.66% and 14.38% for FY23 to FY25 (DRHP p.154).p.154

    “Return-on-equity figures are distorted by the negative starting net worth; the document also gives adjusted return on equity of 25.04%, 16.66% and 14.38% for FY23 to FY25 (DRHP p.154).”

  10. 10
    Earnings qualityThe company and some subsidiaries have made losses in the past (DRHP p.26).p.26

    “The company and some subsidiaries have made losses in the past (DRHP p.26).”

  11. 11
    Earnings qualityThere are no auditor qualifications that have not been given effect in the restated accounts (DRHP p.24).p.24

    “There are no auditor qualifications that have not been given effect in the restated accounts (DRHP p.24).”

  12. 12
    Earnings qualityTrade receivable days were 103 in FY23, 108 in FY24, 122 in FY25 and 128 for the six months to September 2025 (DRHP p.572).p.572

    “Trade receivable days were 103 in FY23, 108 in FY24, 122 in FY25 and 128 for the six months to September 2025 (DRHP p.572).”

  13. 13
    The balance sheetThe negative net worth in March 2023 arose from an amalgamation adjustment reserve on the common-control acquisition of the post-harvest and seeds businesses (DRHP p.73).p.73

    “The negative net worth in March 2023 arose from an amalgamation adjustment reserve on the common-control acquisition of the post-harvest and seeds businesses (DRHP p.73).”

  14. 14
    The balance sheetIn 2025 Alpha Wave Ventures II and UPL Corporation acquired shares, and Advanta's Mauritius subsidiary acquired Decco Holdings UK (DRHP p.343).p.343

    “In 2025 Alpha Wave Ventures II and UPL Corporation acquired shares, and Advanta's Mauritius subsidiary acquired Decco Holdings UK (DRHP p.343).”

  15. 15
    What the money is forThe offer is made under Regulation 6(2) of the SEBI rules because the company did not meet the net-tangible-asset and net-worth conditions of Regulation 6(1)(a) and 6(1)(c) in the preceding years; at least 75% of the net offer must therefore go to qualified institutional buyers (DRHP p.631).p.631

    “The offer is made under Regulation 6(2) of the SEBI rules because the company did not meet the net-tangible-asset and net-worth conditions of Regulation 6(1)(a) and 6(1)(c) in the preceding years; at least 75% of the net offer must therefore go to qualified institutional buyers (DRHP p.631).”

  16. 16
    Who is sellingup to 7,995,390 and KIA EBT Scheme 2 up to 2,610, a total of 36,105,578 (DRHP p.2).p.2

    “up to 7,995,390 and KIA EBT Scheme 2 up to 2,610, a total of 36,105,578 (DRHP p.2).”

  17. 17
    PromotersThe promoter is UPL Limited (DRHP p.22).p.22

    “The promoter is UPL Limited (DRHP p.22).”

  18. 18
    PromotersProceedings against UPL include 39 criminal, 130 tax and 32 regulatory matters involving ₹8,363.86 million (DRHP p.25).p.25

    “Proceedings against UPL include 39 criminal, 130 tax and 32 regulatory matters involving ₹8,363.86 million (DRHP p.25).”

  19. 19
    What changed just before the IPOFormation, company incorporated in June 2022; seeds business transferred from UPL in December 2022 (DRHP p.73).p.73

    “Formation, company incorporated in June 2022; seeds business transferred from UPL in December 2022 (DRHP p.73).”

  20. 20
    What changed just before the IPONew shareholders, Alpha Wave Ventures II and UPL Corporation in 2025 (DRHP p.343).p.343

    “New shareholders, Alpha Wave Ventures II and UPL Corporation in 2025 (DRHP p.343).”

  21. 21
    What changed just before the IPODecco, acquisition of Decco Holdings UK in 2025 (DRHP p.343).p.343

    “Decco, acquisition of Decco Holdings UK in 2025 (DRHP p.343).”

  22. 22
    What changed just before the IPODebt, borrowings cut from ₹2,950 million to ₹411 million in six months (DRHP p.24).p.24

    “Debt, borrowings cut from ₹2,950 million to ₹411 million in six months (DRHP p.24).”

  23. 23
    What changed just before the IPOSplit and bonus, the face value was sub-divided from ₹10 to ₹1 in August 2024, and a bonus issue of four shares for every one held was allotted on 11 September 2024 (DRHP p.134).p.134

    “Split and bonus, the face value was sub-divided from ₹10 to ₹1 in August 2024, and a bonus issue of four shares for every one held was allotted on 11 September 2024 (DRHP p.134).”

  24. 24
    What changed just before the IPOLast allotment, 50,146,636 shares were allotted to UPL Corporation Limited at ₹855 on 25 September 2025, after 10,909,093 shares to Alpha Wave Ventures II, LP at ₹796.40 in March 2025 (DRHP p.101).p.101

    “Last allotment, 50,146,636 shares were allotted to UPL Corporation Limited at ₹855 on 25 September 2025, after 10,909,093 shares to Alpha Wave Ventures II, LP at ₹796.40 in March 2025 (DRHP p.101).”

  25. 25
    What changed just before the IPOPublic company, the company became a public limited company in October 2022 (DRHP p.2); there has been no change of statutory auditor in the three years before the filing (DRHP p.127), and no pre-IPO placement is contemplated (DRHP p.45).p.2

    “Public company, the company became a public limited company in October 2022 (DRHP p.2); there has been no change of statutory auditor in the three years before the filing (DRHP p.127), and no pre-IPO placement is contemplated (DRHP p.45).”

  26. 26
    Capacity and expansionProduction relies on contract growers and processing partly on third-party plants (DRHP p.26).p.26

    “Production relies on contract growers and processing partly on third-party plants (DRHP p.26).”

  27. 27
    Capacity and expansionNo expansion is funded by the offer (DRHP p.23).p.23

    “No expansion is funded by the offer (DRHP p.23).”

  28. 28
    Market size and industry structureThe industry report cited in the offer document estimates the global seeds market at $51.9 billion in CY2025, forecast to reach $68.0 billion by CY2030, and the post-harvest treatment market at $2.1 billion, forecast to reach $3.0 billion (DRHP p.22).p.22

    “The industry report cited in the offer document estimates the global seeds market at $51.9 billion in CY2025, forecast to reach $68.0 billion by CY2030, and the post-harvest treatment market at $2.1 billion, forecast to reach $3.0 billion (DRHP p.22).”

  29. 29
    Competitive positionProprietary germplasm built over more than 50 years of R&D (DRHP p.22).p.22

    “Proprietary germplasm built over more than 50 years of R&D (DRHP p.22).”

  30. 30
    Competitive positionGlobal reach, seeds sold in 74 countries (DRHP p.22).p.22

    “Global reach, seeds sold in 74 countries (DRHP p.22).”

  31. 31
    Peers the company namedThe table also lists Corteva (DRHP p.152).p.152

    “The table also lists Corteva (DRHP p.152).”

  32. 32
    Risks, in plain wordsWeather and disease. Crop failures affect supply and demand (DRHP p.25).p.25

    “Weather and disease. Crop failures affect supply and demand (DRHP p.25).”

  33. 33
    Risks, in plain wordsProduction costs. About 38% of revenue (DRHP p.26).p.26

    “Production costs. About 38% of revenue (DRHP p.26).”

  34. 34
    Risks, in plain wordsContract growers. Short-term, seasonal arrangements (DRHP p.26).p.26

    “Contract growers. Short-term, seasonal arrangements (DRHP p.26).”

  35. 35
    Risks, in plain wordsField corn. More than half of recent seeds revenue (DRHP p.26).p.26

    “Field corn. More than half of recent seeds revenue (DRHP p.26).”

  36. 36
    Risks, in plain wordsAmericas. About 40% of revenue (DRHP p.26).p.26

    “Americas. About 40% of revenue (DRHP p.26).”

  37. 37
    Risks, in plain wordsSeasonality. Sales and cash swing through the year (DRHP p.26).p.26

    “Seasonality. Sales and cash swing through the year (DRHP p.26).”

  38. 38
    Litigation and regulatory mattersThe 15 criminal proceedings against the company arose from notices by statutory authorities (DRHP p.25).p.25

    “The 15 criminal proceedings against the company arose from notices by statutory authorities (DRHP p.25).”

  39. 39
    Litigation and regulatory mattersThe company has filed 37 criminal proceedings (DRHP p.25).p.25

    “The company has filed 37 criminal proceedings (DRHP p.25).”

  40. 40
    Related-party transactionsThe company acquired its businesses from UPL group companies (DRHP p.73).p.73

    “The company acquired its businesses from UPL group companies (DRHP p.73).”

  41. 41
    Key figuresGrowth | EBITDA margin FY23 → FY25 | 22.7% → 24.7% | (DRHP p.154)p.154

    “Growth | EBITDA margin FY23 → FY25 | 22.7% → 24.7% | (DRHP p.154)”

  42. 42
    Key figuresIssue | Fresh issue | none | (DRHP p.2)p.2

    “Issue | Fresh issue | none | (DRHP p.2)”

  43. 43
    Key figuresIssue | Offer for sale | 36,105,578 shares | (DRHP p.2)p.2

    “Issue | Offer for sale | 36,105,578 shares | (DRHP p.2)”

  44. 44
    Key figuresBalance sheet | Net worth, September 2025 | ₹7,321.3 cr | (DRHP p.24)p.24

    “Balance sheet | Net worth, September 2025 | ₹7,321.3 cr | (DRHP p.24)”

  45. 45
    Key figuresBalance sheet | Total borrowings, September 2025 | ₹41.1 cr | (DRHP p.24)p.24

    “Balance sheet | Total borrowings, September 2025 | ₹41.1 cr | (DRHP p.24)”

  46. 46
    Key figuresWorth reading | Free cash flow FY25 | ₹360.2 cr | (DRHP p.154)p.154

    “Worth reading | Free cash flow FY25 | ₹360.2 cr | (DRHP p.154)”

  47. 47
    Key figuresWorth reading | Cases against promoters | 39 criminal, 130 tax, 32 regulatory, ₹836.4 cr | (DRHP p.25)p.25

    “Worth reading | Cases against promoters | 39 criminal, 130 tax, 32 regulatory, ₹836.4 cr | (DRHP p.25)”

  48. 48
    Key figuresWorth reading | Net working capital days, six months to September 2025 | 190 | (DRHP p.154)p.154

    “Worth reading | Net working capital days, six months to September 2025 | 190 | (DRHP p.154)”

  49. 49
    Key figuresBefore the IPO | Revenue FY23 → FY25 | ₹4,291.7 cr → ₹5,565.7 cr | (DRHP p.24)p.24

    “Before the IPO | Revenue FY23 → FY25 | ₹4,291.7 cr → ₹5,565.7 cr | (DRHP p.24)”

  50. 50
    Key figuresBefore the IPO | PAT FY23 → FY25 | ₹602.7 cr → ₹921.5 cr | (DRHP p.24)p.24

    “Before the IPO | PAT FY23 → FY25 | ₹602.7 cr → ₹921.5 cr | (DRHP p.24)”

  51. 51
    Key figuresBefore the IPO | Receivable days FY23 → FY25 | 103 → 122 | (DRHP p.572)p.572

    “Before the IPO | Receivable days FY23 → FY25 | 103 → 122 | (DRHP p.572)”

  52. 52
    Key figuresBefore the IPO | Bonus issue | 4:1, September 2024 | (DRHP p.134)p.134

    “Before the IPO | Bonus issue | 4:1, September 2024 | (DRHP p.134)”

  53. 53
    Key figuresBefore the IPO | Share split | ₹10 to ₹1, August 2024 | (DRHP p.134)p.134

    “Before the IPO | Share split | ₹10 to ₹1, August 2024 | (DRHP p.134)”

  54. 54
    Key figuresBefore the IPO | Pre-IPO placement | none | (DRHP p.45)p.45

    “Before the IPO | Pre-IPO placement | none | (DRHP p.45)”

  55. 55
    Key figuresBefore the IPO | Last allotment before the IPO | ₹855 a share, September 2025 | (DRHP p.101)p.101

    “Before the IPO | Last allotment before the IPO | ₹855 a share, September 2025 | (DRHP p.101)”

  56. 56
    Key figuresBefore the IPO | Auditor change | none in the last three years | (DRHP p.127)p.127

    “Before the IPO | Auditor change | none in the last three years | (DRHP p.127)”

  57. 57
    Key figuresBefore the IPO | Converted to a public company | October 2022 | (DRHP p.2)p.2

    “Before the IPO | Converted to a public company | October 2022 | (DRHP p.2)”

  58. 58
    Key figuresWho is involved | Industry | Agriculture and agrochemicals | (DRHP p.2)p.2

    “Who is involved | Industry | Agriculture and agrochemicals | (DRHP p.2)”

  59. 59
    Key figuresWho is involved | Promoter | UPL Limited | (DRHP p.411)p.411

    “Who is involved | Promoter | UPL Limited | (DRHP p.411)”

  60. 60
    Key figuresWho is involved | Selling shareholder | UPL Limited (promoter), 28,107,578 shares | (DRHP p.2)p.2

    “Who is involved | Selling shareholder | UPL Limited (promoter), 28,107,578 shares | (DRHP p.2)”

  61. 61
    Key figures(investor), 7,995,390 shares | (DRHP p.2)p.2

    “(investor), 7,995,390 shares | (DRHP p.2)”

  62. 62
    Key figuresWho is involved | Selling shareholder | KIA EBT Scheme 2 (investor), 2,610 shares | (DRHP p.2)p.2

    “Who is involved | Selling shareholder | KIA EBT Scheme 2 (investor), 2,610 shares | (DRHP p.2)”

  63. 63
    Key figuresLtd., 11.1% before the issue | (DRHP p.141)p.141

    “Ltd., 11.1% before the issue | (DRHP p.141)”

  64. 64
    Key figuresWho is involved | Pre-IPO investor | Alpha Wave Ventures II, LP, 10.7% before the issue | (DRHP p.141)p.141

    “Who is involved | Pre-IPO investor | Alpha Wave Ventures II, LP, 10.7% before the issue | (DRHP p.141)”

Advanta Enterprises IPO: before the IPO

The record up to the issue and what changed in the company's capital and auditors, from the offer document.

Revenue FY23 → FY25
₹4,291.7 cr → ₹5,565.7 cr
PAT FY23 → FY25
₹602.7 cr → ₹921.5 cr
Receivable days FY23 → FY25
103 → 122
Bonus issue
4:1, September 2024
Share split
₹10 to ₹1, August 2024
Pre-IPO placement
none
Last allotment before the IPO
₹855 a share, September 2025
Auditor change
none in the last three years
Converted to a public company
October 2022

What changed just before the IPO, in the study

Advanta Enterprises IPO: checks

Factual conditions, each with a fixed threshold, read from the key figures. A condition met is a fact to read up on in the study, not a verdict on the issue; meeting none is not a verdict either.

  • Cases against promoters

    Cases against promoters: 39 criminal, 130 tax, 32 regulatory, ₹836.4 cr.

  • Working capital over 150 days

    Working capital is 190 days of revenue.

Advanta Enterprises IPO: questions answered

When will the Advanta Enterprises IPO open?

No dates or price band yet. The company filed its draft offer document on 19 Jan 2026. The dates and the band come with the red herring prospectus, after SEBI has reviewed the draft.

What are Advanta Enterprises's financials?

Revenue went ₹4,291.7 cr to ₹5,565.7 cr (FY23 to FY25), 13.9% a year. Profit after tax went ₹602.7 cr to ₹921.5 cr (FY23 to FY25), 23.7% a year. All figures are from the offer document's restated statements.

The growth record, in the study

Is the Advanta Enterprises IPO a fresh issue or an offer for sale?

A fresh issue of ₹0 crore, which goes to the company.

Who is selling, in the study

What is the Advanta Enterprises IPO GMP?

newboard does not publish a grey-market premium. Grey-market deals happen outside the stock exchanges, are not regulated, and leave no public record of who traded at what price. What is on record is the offer document, read on this page, and the exchanges' bid book.

Advanta Enterprises IPO: the next step, on Telegram

A message when there is news on its price band, bidding, allotment status, listing day and use-of-proceeds reports. Free, no account, leave in one tap. Send /stop to end it.

Not on this page yet: the peer table the issuer printed. Each is added when the pipeline extracts it from the offer document.

The figures on this page are the company's own, taken from its filings with the exchanges and SEBI, and every number links to the document and page it came from. They are reproduced as stated, not verified independently, and they are not forecasts by newboard.in. Nothing here is investment advice, a research report or a recommendation. newboard.in is not a SEBI-registered research analyst or investment adviser.